Hi. The additional information you have given all confirm my suspicion that your friend has an aggressive tumor subtype. In particular, she has a less common subtype called a "triple negative" tumor, owing to the fact that the ER, PR and HER-2 assays are all negative. This tumor is resistant to some of the usual cancer treatment like Herceptin or hormonal therapy, but may be responsive to chemotherapy which contains anthracyclines (e.g. Epirubicin), taxanes (e.g. Docetaxel), or platinum (e.g. Cisplatin) drugs. There is a foundation, the Triple Negative Breast Cancer Foundation, which may be able to provide you with additional information and help regarding your friend's condition (link: http://www.tnbcfoundation.org/index.html).
To Dr Rogue,
She is 41. Her assays were all negative. I do not know what chemo she wa on. One relative an aunt died of breast cancer but she lived awhile with it.
Hi. I'm sorry to hear about what your friend is going through. All the things you've said about your friend's condition - the rapid doubling of the tumor's size, the development of skin and brain metastases soon after chemotherapy - all point to an aggressive type of breast cancer. It is very possible for aggressive tumor types to develop resistance to the initial chemotherapy regimen and spread rapidly.
My impression of your friend's case is that the doctors were not able to pick up the various hints that the tumor they're dealing with is aggressive. Maybe if they did, they could have managed the case more aggressively (e.g. performed a mastectomy instead of a lumpectomy). However, it may also be unfair to judge the doctors' decision because we already have the benefit of hindsight. We know how your friend turned out, while those doctors did not at the time they made their management decisions.
I do think that the skin metastases which were misdiagnosed as shingles was clearly an error on the part of the doctor and could have delayed the administration of proper treatment (radiation and chemotherapy). But even with the correct diagnosis, I don't think the brain metastases could have been prevented.
Your friend's case has piqued my interest. I would appreciate it if you can provide additional information about her case. How old is she? Did she have any relatives who had breast cancer? Were assays for estrogen receptor (ER), progesterone receptor (PR), and HER-2 done? What were the results? What drugs were used for her initial chemotherapy? I hope to hear more from you soon.